Clinical trials in oncology have been greatly influenced by COVID-19, but even before the pandemic, there were many assumptions and myths surrounding clinical trials. On Wednesday, December 2, Senior Director of Education and Program Development of AONN+ Emily Gentry, BSN, RN, HON-ONN-CG, OCN; and panelists Leah Szumita, MS, RN, CCRN, ACNS-BC; Ashley Giacobbi, MSN, RN, ACNS-BC, AOCNS; and Mary Van Cleave, BSN, RN, OCN, discussed the impact of COVID-19 on clinical trials and the barriers patients face when enrolling in trials.
